This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Life Sciences & Health Care

Deloitte Corporate Finance LLC

Deloitte Corporate Finance LLC (DCF), is committed to providing investment banking services to the Life Science and Healthcare industry. We have extensive transaction experience in health care merger and acquisition, financing, recapitalizations, balance sheet restructurings, capital raises, and strategic business development.

As the corporate finance practice of the U.S. member firm of Deloitte Touche Tohmatsu Limited, Deloitte Corporate Finance LLC has access to one of the largest Healthcare Consulting practices in the US and industry knowledge, relationships and expertise at many of the largest life sciences and health care companies.

DCF is able to leverage the global network and capabilities of the corporate finance practices of the DTTL Member Firms, offering clients the ability to execute transactions on global basis. By advising clients across the range of health care sectors, we have developed specialization in health care services, health plans, medical devices, health care information technology, and pharmaceuticals.

Contact our Life Sciences and Healthcare leaders: Simon Gisby and Michael McArthur.

Your Deal

  • Life Sciences and Health Care Transactions
    Discover why so many Life Sciences and Health Care organizations trust us when they need top-quality investment banking advisory services.

Learn more about Deloitte's coverage of the Life Sciences, Health Plans and Health Care Providers industries.

Latest Insights from Deloitte.com

  • Smart Choices – Telling Our M&A Health Reform Story
    National health reform is here. As it continues to trigger sweeping changes in the marketplace, it is even more critical that in the world of M&A, every phase in the deal lifecycle be interconnected and that your M&A strategy take into consideration the known and potential effects from the reform. View our latest video where our M&A healthcare leaders show how linking the phases of the transaction life cycle is critical to completing successful transactions and creating shareholder value.
  • 2009 Survey of Health Care Consumers
    The findings of our second annual study suggest that growing numbers of health care consumers want to be actively engaged. Learn more.
  • Medical Tourism: Update and Implications - 2009 Report
    In this updated study, we focus on medical tourism guidelines, the role of health plans, state legislative initiatives, growth of foreign medical sites, and the impact of the U.S. economic downturn on medical tourism’s growth.
  • Retail Medical Clinics: Update and Implications - 2009 Report
    Receiving low-cost, non-urgent health care services at a retail clinic is an attractive alternative to traditional long waits in a physician’s office. Learn more.
  • The Medical Home: A Solution to Chronic Care Management?
    This paper offers a strategic perspective on addressing the challenge of chronic care management, and reducing overall health care.
  • The Evolving e-Prescribing Landscape
    Explore the e-Prescribing landscape including the regulatory environment, strategies for key stakeholders and challenges on the road to adoption of the process and technology.

 

Learn More

  • ExternalURL
    M&A and Healthcare
    Industry Advantage
  • ExternalURL
    M&A and Life Sciences
    Industry Advantage

Stay Connected